Medical Device News Magazine

Toyochem Develops Soft Skin Polyurethane-based Pressure-Sensitive Adhesives

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

February 24, 2021

Toyochem Co. has released a new line of “Soft Skin” polyurethane-based pressure-sensitive adhesives (PSAs) designed to meet the growing demand for safe, low-trauma medical devices formulated for sensitive skin individuals. Suitable applications include surgical tapes and dressing films customized for the medical and healthcare fields.

The new adhesive system offers high moisture permeability and low skin exfoliation for pain-free removal or repositioning of the adhesive material. In addition, the new compositions do not contain silicones or other substances that may contaminate coatings lines or processing environments.
Drawing on its expertise in urethane chemistry in the development of protective films for the electronics industry, Toyochem engineered a medical-grade urethane composition with a uniquely soft and flexible urethane-based composition. The product adheres well to the skin while causing very low trauma to the keratin layer when the dressing is removed or repositioned. “The challenge is finding the right balance between adhesion and release,” said Nao Nakamura, general manager of Toyochem’s adhesives division.
Nakamura added, “Materials for medical devices and dressing must have the elasticity to conform to skin surfaces and movement in order to prevent water, dirt, or bacteria from entering and infecting the wound. They also need to have the right amount of release to prevent trauma to the tender skin surrounding it. With the new development, we’re able to strike a fine balance that meets both requirements.”
Moreover, Toyochem’s new urethane PSA system demonstrates exceptional moisture permeability with water vapor transmission rates of 2,000g/m2/24 hours, achieving values that are considerably higher than those of conventional acrylic PSAs. Poor moisture permeability can trap heat and water vapors between the skin and adhesive layer, often leading to skin irritation, maceration, and even bacterial growth. Toyochem’s PSA product, however, is designed to substantially raise the water vapor transmission ability of the adhesive layer, allowing moisture to be evaporated to the outside of the adhesive material.
At present, silicones are widely used in the manufacturing of wound management devices, due to their biocompatibility. The new PSAs from Toyochem, however, is silicone-free and have been proven safe for human skin contact. They can be customized to meet International Standards ISO 10993-1, making it a more user- and cost-friendly alternative to silicone adhesives.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”